New approaches to some of the most serious unmet health challenges of our time
An ingredient in a medicinal tea brewed from tree bark by tribal healers on the South Pacific island of Samoa — studied by scientists over the last 25 years — is showing significant promise as a drug lead in the long-sought goal of eliminating the AIDS virus from its sanctuaries in the body and thus eradicating the disease, a scientist said here today.
Speaking at the 246th National Meeting & Exhibition of the American Chemical Society (ACS), Paul A. Wender, Ph.D., described efficient new ways of making prostratin and related leads, as well as other drug candidates first discovered in sea creatures, that appear even more effective for AIDS and have applications for Alzheimer’s disease and cancer.
In his presentation, Wender focused on fundamentally new approaches to some of the most serious unmet health challenges of our time. He is with Stanford University. They include the eradication of AIDS, developing medicines that stop the progression of Alzheimer’s disease and treating resistant cancer — the major cause of chemotherapy failure for most cancers. Almost 7,000 presentations on new molecular discoveries in science and other topics are on the agenda for the meeting of the world’s largest scientific society, which continues through Thursday in the Indiana Convention Center and downtown hotels.
Wender leads a scientific team at Stanford University that first developed a way to make the tea ingredient, prostratin, in large amounts from readily available ingredients. He described how that initial synthesis broke down a major barrier to probing prostratin’s antiviral effects. Until then, scientists had to extract prostratin from the bark of the Samoan mamala tree, and only tiny and variable amounts were so obtained. Samoa is where another scientist, Paul Cox, in 1987 heard a native healer praise mamala bark tea as a remedy for viral hepatitis. It led scientists at the National Cancer Institute to analyze the bark and identify prostratin as a key ingredient. Wender’s synthesis of prostratin opened the door to research on the substance and enabled his team to change prostratin’s architecture.
“We now have made synthetic variants of prostratin, called analogs, that are 100 times more potent than the natural product,” Wender said. “That’s part of the basis for our approach to advancing potentially transformative treatments for AIDS, Alzheimer’s disease and resistant cancer. The mamala tree did not start making prostratin millions of years ago to treat a disease that appeared in the 20th century. The same is true for other substances that occur naturally in plants and animals. But we now have the tools to read nature’s library and use the lessons learned there to design, make and study new molecules that address unmet medical needs. This “function-oriented” approach seeks to identify useful parts of molecules and then, based on this knowledge, to design new and more readily synthesized molecules that work better or work in totally new ways. This is a well-validated strategy, perhaps best exemplified by the emergence of modern aviation from knowledge of how birds fly.”
Those new versions of prostratin show promise in laboratory tests for both preventing HIV from infecting human cells and awakening dormant HIV viruses that are hiding inside human latently infected cells. Latent HIV cell reservoirs are untouchable by today’s antiviral medicines. Antiviral medicines reduce active virus levels in patients’ blood and keep patients healthy. But when patients stop the medication, the hibernating HIV in reservoirs awakens to resupply active virus. Prostratin flushes HIV out of its cellular sanctuaries so that antiviral drugs can attack and hopefully eradicate the HIV from the body. In essence, if one wants to eliminate a weed, one needs to get rid of its roots.
Wender’s group used those same “function-oriented” approaches in the design and synthesis of analogs of bryostatin, a substance that occurs naturally in sea creatures called bryozoans.
“Bryostatin has shown great promise in laboratory experiments as the basis for development of potentially transformative medicines for cancer, Alzheimer’s disease and the eradication of HIV/AIDS,” Wender said. “However, its limited supply from natural sources has slowed research, and as with prostratin, it was not evolved in nature for modern therapeutic use. We have overcome both the supply and performance barriers by designing simpler and thus more readily synthesized analogs of bryostatin — over 100 of them so far. When tested in various assays related to HIV/AIDS eradication, these analogs are up to 1,000-fold more potent in flushing HIV out of its hiding places than prostratin. Much needs to be done, but we are on a promising trajectory.”
The Latest on: Transformative medicines
- Harold L. Paz, M.D., named executive vice president and chancellor for health affairs at Ohio State on February 20, 2019 at 7:29 am
Hershey Medical Center, senior vice president for health affairs, dean of the College of Medicine and president/CEO of the Penn State Hershey Health System from 2006 to 2014. He left Penn State to joi... […]
- Pasadena’s Kaiser Permanente School of Medicine to Open Summer 2020 on February 20, 2019 at 5:20 am
Pasadena’s Kaiser Permanente School of Medicine announced Tuesday that it has received ... The school aims to prepare future physicians to become collaborative, transformative leaders committed to pre... […]
- The Medicines Company to Announce Fourth-Quarter and Full-Year 2018 Financial Results on February 27 on February 20, 2019 at 4:05 am
The Medicines Company is a biopharmaceutical ... The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians, and ... […]
- Kaiser Permanente School of Medicine to Open Summer 2020 on February 19, 2019 at 11:00 am
transformative leaders committed to prevention, fluent in data-driven care, and adept at addressing the needs of underserved patients and communities. "Kaiser Permanente is driving to transform health ... […]
- Pasadena-based Kaiser Permanente School of Medicine receives preliminary accreditation, will accept students this year on February 19, 2019 at 8:06 am
transformative leaders committed to prevention, fluent in data, and adept at addressing the needs of underserved patients and communities. “Kaiser Permanente is driving to transform health and health ... […]
- When Will The Editas Medicine Slide End? on February 18, 2019 at 1:03 pm
Editas Medicine (EDIT) has been on a noticeable ... In fact, if you still believe in the transformative power of blockchain, it means that many of these technologies are back to early adopter ... […]
- For Lourdes oncologist, magic is great medicine on February 13, 2019 at 9:18 am
I am giving the mind a break from worry. Magic is great medicine.” Saul, 62, has been studying magic for more than 10 years. He first discovered its transformative power while his son Michael was a te... […]
- Five solutions offered for achieving gender equality in medicine and science on February 8, 2019 at 8:32 am
Toronto - Women's representation in science and medicine has slowly increased over the past few ... Rotman is a catalyst for transformative learning, insights and public engagement, bringing together ... […]
- Blueprint Medicines to Present at Upcoming Investor Conferences in February on February 7, 2019 at 1:01 pm
... Medicines Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developin... […]
- Transformative Healthcare/Fallon Ambulance Service partner with Northeastern University for innovative new EMT training on February 7, 2019 at 9:28 am
Whether they are heading into careers in medicine, healthcare management, or medical research, the real-world experience they will gain from working this winter and spring as EMTs with Fallon and Tran... […]
via Google News and Bing News